Literature DB >> 28460563

A review of sleep disorders and melatonin.

Zizhen Xie1, Fei Chen1, William A Li2, Xiaokun Geng3, Changhong Li1, Xiaomei Meng1, Yan Feng1, Wei Liu1, Fengchun Yu1.   

Abstract

Sleep disorders are a group of conditions that affect the ability to sleep well on a regular basis and cause significant impairments in social and occupational functions. Although currently approved medications are efficacious, they are far from satisfactory. Benzodiazepines, antidepressants, antihistamines and anxiolytics have the potential for dependence and addiction. Moreover, some of these medications can gradually impair cognition. Melatonin (N-acetyl-5-methoxytryptamine) is an endogenous hormone produced by the pineal gland and released exclusively at night. Exogenous melatonin supplementation is well tolerated and has no obvious short- or long-term adverse effects. Melatonin has been shown to synchronize the circadian rhythms, and improve the onset, duration and quality of sleep. It is centrally involved in anti-oxidation, circadian rhythmicity maintenance, sleep regulation and neuronal survival. This narrative review aims to provide a comprehensive overview of various therapeutic functions of melatonin in insomnia, sleep-related breathing disorders, hypersomnolence, circadian rhythm sleep-wake disorders and parasomnias. Melatonin offers an alternative treatment to the currently available pharmaceutical therapies for sleep disorders with significantly less side effects.

Entities:  

Keywords:  Melatonin; circadian rhythm; hypersomnolence; insomnia; melatonin receptors; neuroprotective agents; parasomnias; sleep disorders; sleep-related breathing disorders

Mesh:

Substances:

Year:  2017        PMID: 28460563     DOI: 10.1080/01616412.2017.1315864

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  56 in total

1.  Need for a standardized technique of nap EEG recordings: results of a national online survey in Italy.

Authors:  Sara Gasparini; Chiara Sueri; Michele Ascoli; Vittoria Cianci; Salvatore Maria Cavalli; Giulia Ferrigno; Vincenzo Belcastro; Umberto Aguglia; Edoardo Ferlazzo
Journal:  Neurol Sci       Date:  2018-08-23       Impact factor: 3.307

2.  Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trial.

Authors:  Bradley Wibrow; F Eduardo Martinez; Erina Myers; Andrew Chapman; Edward Litton; Kwok M Ho; Adrian Regli; David Hawkins; Andrew Ford; Frank M P van Haren; Simon Wyer; Joe McCaffrey; Alan Rashid; Erin Kelty; Kevin Murray; Matthew Anstey
Journal:  Intensive Care Med       Date:  2022-02-27       Impact factor: 17.440

Review 3.  Drug Safety in Episodic Migraine Management in Adults. Part 2: Preventive Treatments.

Authors:  Abigail L Chua; Sandhya Mehla; Yulia Y Orlova
Journal:  Curr Pain Headache Rep       Date:  2022-05-19

Review 4.  Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Colin J Mahoney; Rebekah M Ahmed; William Huynh; Sicong Tu; Jonathan D Rohrer; Richard S Bedlack; Orla Hardiman; Matthew C Kiernan
Journal:  CNS Drugs       Date:  2021-05-15       Impact factor: 5.749

5.  Association between MTNR1B polymorphisms and obesity in African American: findings from the Jackson Heart Study.

Authors:  Cynthia Tchio; Solomon K Musani; Alexander Quarshie; Gianluca Tosini
Journal:  BMC Med Genomics       Date:  2021-05-21       Impact factor: 3.063

Review 6.  Machine and Deep Learning in Molecular and Genetic Aspects of Sleep Research.

Authors:  Michael Elgart; Susan Redline; Tamar Sofer
Journal:  Neurotherapeutics       Date:  2021-04-07       Impact factor: 6.088

Review 7.  Molecular Mechanism of Neuroprotective Effect of Melatonin on Morphine Addiction and Analgesic Tolerance: an Update.

Authors:  Ling-Yan Su; Qianjin Liu; Lijin Jiao; Yong-Gang Yao
Journal:  Mol Neurobiol       Date:  2021-06-19       Impact factor: 5.590

8.  Screen use before bedtime: Consequences for nighttime sleep in young children.

Authors:  Angela D Staples; Caroline Hoyniak; Maureen E McQuillan; Victoria Molfese; John E Bates
Journal:  Infant Behav Dev       Date:  2020-12-29

Review 9.  Possible benefits of exogenous melatonin for individuals on dialysis: a narrative review on potential mechanisms and clinical implications.

Authors:  Seyed Majid Mousavi Movahhed
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-06-07       Impact factor: 3.000

10.  Association of changes in self-reported sleep duration with mild cognitive impairment in the elderly: a longitudinal study.

Authors:  Xiyan Wang; Yan Chen; Bixuan Yue; Sifan Li; Qitong Liu; Qiaoyu Li; Lin Li; Jiangwei Sun
Journal:  Aging (Albany NY)       Date:  2021-06-06       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.